In a nutshell This study looked at the safety and effectiveness of venetoclax (Venclexta) in combination with other treatments for elderly patients with acute myeloid leukemia (AML). The study found that this newer treatment may be effective in these patients. Some background Acute myeloid leukemia is a cancer of the bone marrow that leads to abnormal...
Read More
In a nutshell This study aimed to assess if a response to treatment within 12 months was linked with an improved quality of life in patients with chronic myeloid leukemia. Researchers concluded that achieving the best treatment response within 12 months was associated with better quality of life in these patients. Some background Chronic myeloid...
Read More
Prior to the 20th century, most people lived about 47 years in the developed world because of infectious diseases. In 1940, the first use of penicillin to treat infectious diseases occurred and penicillin became available in 1945 to the general public. Science and research conducted throughout the 1950s, 60s, and 70s, created more antibiotics so that life...
Read More
In a nutshell This study evaluated the effectiveness and safety of duvelisib in patients with chronic lymphocytic leukemia (CLL). This study concluded that duvelisib may be an effective new therapy with manageable side effects. Some background CLL is the most common type of leukemia in adults in the U.S. Although therapy options have increased, many...
Read MoreIn a nutshell This study looked at the risk and outcomes of fluid build-up around the lungs in patients with leukemia receiving dasatinib (Sprycel) treatment. The study found that age was a risk factor for developing lung fluid in these patients but overall survival was not affected. Some background Leukemia is a cancer of the bone marrow that leads...
Read More
In a nutshell This study observed the safety and effectiveness of the drug Gemtuzumab Ozagamicin (Mylotarg) when given to children with acute myeloid leukemia unresponsive to treatment. The authors found the treatment to be effective in children who became unresponsive to bone marrow transplant therapy. Some background Acute Myeloid...
Read More
In a nutshell This study observed the effects of a protein treatment called interferon-alpha in patients with acute leukemia unresponsive to transplant therapy. The authors found that this treatment was effective in improving treatment response and survival in these patients. Some background Interferon-alpha (IFN-a) is a type of...
Read More
In a nutshell This study evaluated the effectiveness and safety of second-generation tyrosine kinase (TK) inhibitors after imatinib (Gleevec) therapy in children and adolescents with chronic myeloid leukemia (CML). The authors concluded that second-generation TK inhibitors may be a viable first-line treatment option for these patients. Some background...
Read More
In a nutshell This study examined the safety and effectiveness of using nilotinib (Tasigna) in patients with chronic myeloid leukemia (CML) unresponsive to other treatment. The study concluded that nilotinib is safe and effective in the treatment of CML unresponsive to imatinib (Gleevec). Some background Chronic myeloid leukemia is a cancer of the...
Read More
In a nutshell This study looked at the evidence for and against green tea and turmeric in the treatment of chronic lymphocytic leukemia (CLL). The study found that there is a lack of evidence of these treatments in treating CLL. Some background Complementary alternative medicine (CAM) are a commonly used group of practices and products that are...
Read More
In a nutshell This study examined the safety and effectiveness of venetoclax (Venclexta) in the treatment of chronic lymphocytic leukemia (CLL). Researchers found that venetoclax was safe and effective in these patients. Some background Chronic lymphocytic leukemia is a type of cancer of the bone marrow that can lead to an abnormal immune system. Over...
Read MoreIn a nutshell This study investigated the occurrence and impact of bone loss in adult patients with lymphoma and leukemia. This study concluded that these patients have significant bone loss compared to the general population. Some background Bone loss is a known consequence of many cancers and their treatments. In healthy adults, bone loss is...
Read More
